| | Per Share | | | Total | |
Initial public offering price | | | $31.00 | | | $500,030,000 |
Underwriting discounts and commissions(1) | | | $2.17 | | | $35,002,100 |
Proceeds to Zymergen Inc., before expenses | | | $28.83 | | | $465,027,900 |
(1) | See the section titled “Underwriting” for a description of the compensation payable to the underwriters. |
J.P. Morgan | | | Goldman Sachs & Co. LLC | ||||||
| | | | | | ||||
BofA Securities | | | Cowen | | | UBS Investment Bank | | | Lazard |